SK
Shrey Kumar
About Shrey Kumar
Shrey Kumar has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Orforb Traders Private Limited and Ilac Healthcare Llp. Formerly with 2 companies, such as Sahast Pharmaceuticals Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ilac Healthcare Llp
AAK-3281
|
Designated Partner | 16 Aug 2017 | 2017 | Active |
Skintressence Private Limited
U46491KA2025PTC210466
|
Director | 04 Nov 2025 | 2025 | Active |
Sahast Medisales Private Limited
U46909KA2024PTC186452
|
Director | 10 Oct 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sahast Pharmaceuticals Private Limited
U51909MH2022PTC387290
|
Director | 21 Jul 2022 | 2022 | Active |
Orforb Traders Private Limited
U51900KA2019PTC121835
|
Director | 25 Feb 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shrey Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shrey Kumar
Shrey Kumar has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Orforb Traders Private Limited and Ilac Healthcare Llp. Formerly with 2 companies, such as Sahast Pharmaceuticals Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Shrey Kumar is associated with 3 companies as Director and Designated Partner.
Shrey Kumar has expertise in General Business, Healthcare.
Shrey Kumar has 9 years in corporate governance.